Incidence and mortality trends in oral and oropharyngeal cancers in China, 2005-2013
- PMID: 30396144
- DOI: 10.1016/j.canep.2018.10.014
Incidence and mortality trends in oral and oropharyngeal cancers in China, 2005-2013
Abstract
Background: Oral and oropharyngeal cancers are among the most common cancers globally. This study aimed to assess the incidence and mortality trends of oral and oropharyngeal cancers in China between 2005 and 2013.
Methods: Estimates of national trends of oral and oropharyngeal cancers were based on the data from Chinese Cancer Registry Annual Reports. The crude incidence rates of oral and oropharyngeal cancers between 2015 and 2035 were evaluated. The age-standardized rate was based on the world standard population.
Results: It was estimated that 285,857 new cases and 132,698 deaths were related to oral and oropharyngeal cancers in China between 2005 and 2013, with mouth and tongue cancers being the most frequently diagnosed and the leading causes of death among all oral and oropharyngeal cancers. The incidence rates of oral and oropharyngeal cancer fluctuated from 1.69 to 1.89 per 100,000 person-years, and the mortality rate showed an increasing trend, ranging from 0.77 and 0.84 per 100,000 person-years. Males were more susceptible than females to oral and oropharyngeal cancers. The incidence and mortality rates of oral and oropharyngeal cancers were significantly higher in urban regions. The crude incidence rates of oral cancers are projected to increase from 2.26 to 3.21 per 100,000 person-years over the next 20 years in China.
Conclusion: The incidence of oral and oropharyngeal cancers fluctuated, whereas the mortality rate showed an upward trend from 2005 to 2013. A heavier burden from oral and oropharyngeal cancers is predicted in the next two decades in China.
Keywords: China; Incidence; Mortality; Oral and oropharyngeal cancers.
Copyright © 2018. Published by Elsevier Ltd.
Similar articles
-
[Incidence and mortality of oral cavity and pharyngeal cancer in China, 2009].Zhonghua Yu Fang Yi Xue Za Zhi. 2013 Jul;47(7):586-91. Zhonghua Yu Fang Yi Xue Za Zhi. 2013. PMID: 24304948 Chinese.
-
Trends in the incidence of oral cavity and oropharyngeal cancers in Spain.Head Neck. 2012 May;34(5):649-54. doi: 10.1002/hed.21793. Epub 2011 Jun 29. Head Neck. 2012. PMID: 21717523
-
Trends in oropharyngeal and oral cavity cancer incidence of human papillomavirus (HPV)-related and HPV-unrelated sites in a multicultural population: the British Columbia experience.Cancer. 2010 Jun 1;116(11):2635-44. doi: 10.1002/cncr.25087. Cancer. 2010. PMID: 20336792
-
Global epidemiology of oral and oropharyngeal cancer.Oral Oncol. 2009 Apr-May;45(4-5):309-16. doi: 10.1016/j.oraloncology.2008.06.002. Epub 2008 Sep 18. Oral Oncol. 2009. PMID: 18804401 Review.
-
The Health System and Policy Implications of Changing Epidemiology for Oral Cavity and Oropharyngeal Cancers in the United States From 1995 to 2016.Epidemiol Rev. 2017 Jan 1;39(1):132-147. doi: 10.1093/epirev/mxw001. Epidemiol Rev. 2017. PMID: 28402398 Review.
Cited by
-
Knowledge of Chinese dentists on HPV, their willingness and barriers to recommend HPV vaccination to patients.Hum Vaccin Immunother. 2021 Aug 3;17(8):2728-2735. doi: 10.1080/21645515.2021.1885967. Epub 2021 Mar 9. Hum Vaccin Immunother. 2021. PMID: 33687314 Free PMC article.
-
Interferon-inducible protein, IFIX, has tumor-suppressive effects in oral squamous cell carcinoma.Sci Rep. 2021 Oct 1;11(1):19593. doi: 10.1038/s41598-021-99157-4. Sci Rep. 2021. PMID: 34599264 Free PMC article.
-
The diverse life-course cohort (DLCC): protocol of a large-scale prospective study in China.Eur J Epidemiol. 2022 Aug;37(8):871-880. doi: 10.1007/s10654-022-00894-1. Epub 2022 Jul 19. Eur J Epidemiol. 2022. PMID: 35856127 Free PMC article.
-
Optimizing oropharyngeal cancer management by using proton beam therapy: trends of cost-effectiveness.BMC Cancer. 2021 Aug 21;21(1):944. doi: 10.1186/s12885-021-08638-2. BMC Cancer. 2021. PMID: 34419008 Free PMC article.
-
Biomarkers in head and neck squamous cell carcinoma: unraveling the path to precision immunotherapy.Front Oncol. 2024 Oct 8;14:1473706. doi: 10.3389/fonc.2024.1473706. eCollection 2024. Front Oncol. 2024. PMID: 39439946 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical